Back to Search Start Over

Identifying the stage of new CLL patients using TK, ZAP-70, CD38 levels.

Authors :
Rivkina A
Vitols G
Murovska M
Lejniece S
Source :
Experimental oncology [Exp Oncol] 2011 Jun; Vol. 33 (2), pp. 99-103.
Publication Year :
2011

Abstract

Unlabelled: Serum thymidine kinase (TK), zeta-associated protein of 70 kDa (ZAP-70) and CD38 levels have been shown to be correlated with survival in chronic lymphocytic leukaemia (CLL).<br />Aim: To investigate the possible correlations between TK, ZAP-70 and CD38 levels as prognostic markers in new diagnosed Rai stages of CLL patients.<br />Methods: 120 CLL patients were enrolled. ELISA was used to measure serum TK level, flow cytomerty - to determine ZAP-70 and CD38 expression applying ZAP-70 Kit and monoclonal antibody to CD38, respectively.<br />Results: Significantly higher levels of TK were found in the high progression group of CLL patients that corresponded to stage II (Rai classification). An elevated level of TK, CD38 and ZAP-70 together was also found in the II stage. The coefficient of correlation between CD38 and ZAP-70 is reliable (p < 0.001). There is also a correlation between the level of TK and the disease stage (p < 0.05). Other parameters do not show this correlation.<br />Conclusion: The determination of TK, ZAP-70 and CD38 together allows patients susceptible to a possible stage of the disease, to be identified. Estimation of the factors at an early stage of the disease may allow an earlier commencement of treatment.

Details

Language :
English
ISSN :
2312-8852
Volume :
33
Issue :
2
Database :
MEDLINE
Journal :
Experimental oncology
Publication Type :
Academic Journal
Accession number :
21716207